BioCentury | Aug 8, 2013
Distillery Therapeutics

Indication: Neurology

...include optimizing the peptide to improve its potency. Theralpha S.A.S. and Flamel Technologies S.A. have THA902...
BioCentury | May 16, 2011
Company News

Flamel, Theralpha deal

...The companies partnered to co-develop a controlled-release formulation of Theralpha's THA902 to treat pain. Flamel will...
...technology and be responsible for further development of the compound, which is named THA902 XL. THA902...
Items per page:
1 - 2 of 2